Cocrystal Pharma, Inc. Common Stock Shares Outstanding

• Cocrystal Pharma, Inc. showed an increase of +35.5% in Common Stock Shares Outstanding from 2024 to 2025.
• This data is from Cocrystal Pharma, Inc.'s annual report (Form 10-K), filed with the SEC on March 31, 2026.
• XBRL data for this metric is available from 2010 to 2025 (16 years of filings). Earlier data may not exist in machine-readable XBRL format as companies adopted electronic filing at different times.
• Over the full 16 years of available data (2010 to 2025), Cocrystal Pharma, Inc.'s Common Stock Shares Outstanding has declined by 69.2%.
• Historical annual values: Fiscal year 2025: 13.78 million shares | Fiscal year 2024: 10.17 million shares | Fiscal year 2023: 10.17 million shares | Fiscal year 2022: 8.14 million shares | Fiscal year 2021: 8.14 million shares | Fiscal year 2020: 70.44 million shares | Fiscal year 2019: 35.15 million shares | Fiscal year 2018: 29.94 million shares | Fiscal year 2017: 24.28 million shares | Fiscal year 2016: 23.80 million shares | Fiscal year 2015: 694.40 million shares | Fiscal year 2014: 122,494 shares | Fiscal year 2013: 0 shares | Fiscal year 2012: 63.14 million shares | Fiscal year 2011: 55.18 million shares | Fiscal year 2010: 44.75 million shares.
• Data sourced from SEC EDGAR public filings as of June 24, 2026.

Last verified: June 24, 2026